A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Overview of attention for article published in Drug Design, Development and Therapy, January 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,866 followers.

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer https://t.co/dbIjFNuAx7

25 Feb 2021

Reply Repost Favourite

'A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer' an article on #ScienceOpen: https://t.co/BjnZcC26EP @DovePress #OpenAccess

08 Feb 2021

Reply Repost Favourite

Dove Medical Press

Article Metrics

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Mentioned by

Citations

Readers on